Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377020565> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4377020565 abstract "<b>Abstract ID 14678</b> <b>Poster Board 471</b> <b>Introduction:</b> Current immune-based therapies for multiple sclerosis (MS) reduce relapses but have limited value in slowing disease progression. Remyelination is considered essential for functional recovery in MS. Activation of the retinoid X receptor (RXR) enhances remyelination by increasing the production of myelin-producing oligodendrocytes. 3-Methyl-5-[(1S,2S)-2-methyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl]-2(E),4(E)-pentadienoic acid (IRX4204) is an investigational drug that preferentially activates the RXR. <b>Objective:</b> The purpose of this study was to determine if IRX4204 administration improves motor recovery and remyelination in a mouse model of MS termed experimental autoimmune encephalomyelitis (EAE). <b>Methods:</b> Female C57Bl/6 mice (20-25 g) were subjected to EAE by immunization with a peptide corresponding to amino acids 35-55 of myelin oligodendrocyte glycoprotein. A solution containing 3 mg/mL of this peptide in phosphate buffered saline (PBS; pH 7.4) was emulsified (1:1 ratio) in Complete Freund’s Adjuvant (CFA). Each mouse received two 100 μL injections of the emulsified mixture subcutaneously. Additionally, each mouse received a 200 μL injection of pertussis toxin dissolved in PBS (1.5 ng/μL) on the day of immunization and again on day post-immunization 2. Mice were then treated orally with either vehicle (NEOBEE; 8 ml/kg/day; n = 10) or IRX4204 (12 mg/kg/day; n = 10) beginning at peak disease (day post-immunization 16). Disease severity was assessed using a clinical scoring scale and white matter loss was assessed following the staining of spinal cord sections with eriochrome cyanine and neutral red. Motor function was assessed weekly using kinematic gait analysis to measure hindleg movements in the sagittal plane while mice walked on a treadmill. Spinal cord concentrations of IRX4204 following daily doses were measured using liquid chromatography in tandem with mass spectrometry. <b>Results:</b> Relative to vehicle, IRX4204 reduced clinical scores and reversed gait deficits in EAE mice. Gait improvements in IRX4204-treated EAE mice were characterized by increased toe heights and the recovery of knee joint movements. These gait improvements were associated with reduced white matter loss in the spinal cord suggestive of enhanced remyelination. Furthermore, spinal cord concentrations of IRX4204 reached levels known to stimulate the differentiation of oligodendrocyte progenitor cells into myelin-making oligodendrocytes. <b>Conclusion:</b> These results support and extend findings from other laboratories which have reported that RXR activation enhances remyelination and reduces motor deficits in mice subjected to EAE. Our findings suggest that IRX4204 may reverse motor deficits in MS by stimulating remyelination." @default.
- W4377020565 created "2023-05-19" @default.
- W4377020565 creator A5000863565 @default.
- W4377020565 creator A5038036911 @default.
- W4377020565 creator A5042266507 @default.
- W4377020565 creator A5061034861 @default.
- W4377020565 creator A5063480387 @default.
- W4377020565 creator A5070512885 @default.
- W4377020565 creator A5091972483 @default.
- W4377020565 date "2023-05-18" @default.
- W4377020565 modified "2023-10-05" @default.
- W4377020565 title "IRX4204 enhances gait recovery in mice subjected to experimental autoimmune encephalomyelitis" @default.
- W4377020565 doi "https://doi.org/10.1124/jpet.122.146780" @default.
- W4377020565 hasPublicationYear "2023" @default.
- W4377020565 type Work @default.
- W4377020565 citedByCount "0" @default.
- W4377020565 crossrefType "proceedings-article" @default.
- W4377020565 hasAuthorship W4377020565A5000863565 @default.
- W4377020565 hasAuthorship W4377020565A5038036911 @default.
- W4377020565 hasAuthorship W4377020565A5042266507 @default.
- W4377020565 hasAuthorship W4377020565A5061034861 @default.
- W4377020565 hasAuthorship W4377020565A5063480387 @default.
- W4377020565 hasAuthorship W4377020565A5070512885 @default.
- W4377020565 hasAuthorship W4377020565A5091972483 @default.
- W4377020565 hasBestOaLocation W43770205651 @default.
- W4377020565 hasConcept C126322002 @default.
- W4377020565 hasConcept C134018914 @default.
- W4377020565 hasConcept C185592680 @default.
- W4377020565 hasConcept C203014093 @default.
- W4377020565 hasConcept C2777619251 @default.
- W4377020565 hasConcept C2777863537 @default.
- W4377020565 hasConcept C2777899865 @default.
- W4377020565 hasConcept C2778486448 @default.
- W4377020565 hasConcept C2778609137 @default.
- W4377020565 hasConcept C2779357208 @default.
- W4377020565 hasConcept C2780640218 @default.
- W4377020565 hasConcept C2780801004 @default.
- W4377020565 hasConcept C529278444 @default.
- W4377020565 hasConcept C71924100 @default.
- W4377020565 hasConcept C8891405 @default.
- W4377020565 hasConcept C98274493 @default.
- W4377020565 hasConceptScore W4377020565C126322002 @default.
- W4377020565 hasConceptScore W4377020565C134018914 @default.
- W4377020565 hasConceptScore W4377020565C185592680 @default.
- W4377020565 hasConceptScore W4377020565C203014093 @default.
- W4377020565 hasConceptScore W4377020565C2777619251 @default.
- W4377020565 hasConceptScore W4377020565C2777863537 @default.
- W4377020565 hasConceptScore W4377020565C2777899865 @default.
- W4377020565 hasConceptScore W4377020565C2778486448 @default.
- W4377020565 hasConceptScore W4377020565C2778609137 @default.
- W4377020565 hasConceptScore W4377020565C2779357208 @default.
- W4377020565 hasConceptScore W4377020565C2780640218 @default.
- W4377020565 hasConceptScore W4377020565C2780801004 @default.
- W4377020565 hasConceptScore W4377020565C529278444 @default.
- W4377020565 hasConceptScore W4377020565C71924100 @default.
- W4377020565 hasConceptScore W4377020565C8891405 @default.
- W4377020565 hasConceptScore W4377020565C98274493 @default.
- W4377020565 hasLocation W43770205651 @default.
- W4377020565 hasOpenAccess W4377020565 @default.
- W4377020565 hasPrimaryLocation W43770205651 @default.
- W4377020565 hasRelatedWork W144669723 @default.
- W4377020565 hasRelatedWork W1541403708 @default.
- W4377020565 hasRelatedWork W2015637511 @default.
- W4377020565 hasRelatedWork W2022406306 @default.
- W4377020565 hasRelatedWork W2331526913 @default.
- W4377020565 hasRelatedWork W2548357668 @default.
- W4377020565 hasRelatedWork W2995289115 @default.
- W4377020565 hasRelatedWork W4226044170 @default.
- W4377020565 hasRelatedWork W4313388172 @default.
- W4377020565 hasRelatedWork W2749200642 @default.
- W4377020565 isParatext "false" @default.
- W4377020565 isRetracted "false" @default.
- W4377020565 workType "article" @default.